On Thursday, Tandem Diabetes Care Inc (TNDM) stock saw a decline, ending the day at $28.59 which represents a decrease of $-1.08 or -3.64% from the prior close of $29.67. The stock opened at $29.63 ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

Tandem Diabetes Care (NASDAQ:TNDM – Free Report) had its target price boosted by Barclays from $58.00 to $60.00 in a research ...

Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Get Free Report) have earned an average recommendation of “Moderate Buy” from the eighteen research firms that are presently covering the stock, ...

On Friday, Tandem Diabetes Care Inc (TNDM) stock saw a decline, ending the day at $30.6 which represents a decrease of $-2.72 or -8.16% from the prior close of $33.32. The stock opened at $33.71 and ...

Tandem Diabetes Care shares ticked up after hours today on third-quarter results that topped the consensus forecast.

GET MORE AI-GENERATED SIGNALS: November 15, 2024, 12:08 pm ET, BY Bill T.- Contributor| Editor: Thomas H. Kee Jr. ( Follow on ...

Insulet saw strong insulin pump adoption among new users with Type 2 diabetes following its recent FDA clearance, while ...

In the last three months, 5 analysts have published ratings on Tandem Diabetes Care (NASDAQ:TNDM), offering a diverse range of perspectives from bullish to bearish. The table below provides a ...

Sales: In the United States, GAAP sales included $1.0 million incremental sales relating to Tandem Choice compared to a sales deferral of $8.2 million. Non-GAAP sales exclude Tandem Choice-related ...

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q3 2024 Earnings Call Transcript November 6, 2024 Tandem Diabetes Care, Inc. beats earnings expectations. Reported EPS is $-0.36, expectations were $-0.4.